Humacyte Inc Warrant
HUMAW
6 hedge funds and large institutions have $384K invested in Humacyte Inc Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
15% more capital invested
Capital invested by funds: $333K → $384K (+$50.8K)
0.16% less ownership
Funds ownership: 0.77% → 0.62% (-0.16%)
33% less funds holding
Funds holding: 9 → 6 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$116K |
| 2 |
LPL Financial
San Diego,
California
|
+$19.6K |
| 3 |
Two Sigma Investments
New York
|
+$13.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$108K |
| 2 |
Walleye Capital
New York
|
-$45.3K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$7.82K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$3.44K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
LPL Financial
San Diego,
California
| $168K | +$19.6K | +31,508 | +13% |
|
|
CAC
2
Cowen and Company
New York
| $112K | +$116K | +187,213 | New |
|
|
SCM
3
Sio Capital Management
New York
| $31K | – | – | – |
|
4
Jane Street
New York
| $30K | – | – | – |
|
|
LP
5
LMR Partners
London,
United Kingdom
| $29.6K | – | – | – |
|
|
6
Two Sigma Investments
New York
| $13K | +$13.4K | +21,649 | New |
|
|
JAIC
7
Josh Arnold Investment Consultant
Edina,
Minnesota
| – | -$108K | -259,974 | Closed |
|
|
8
Walleye Capital
New York
| – | -$45.3K | -108,901 | Closed |
|
|
CH
9
CVI Holdings
Wilmington,
Delaware
| – | -$7.82K | -18,802 | Closed |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| – | -$3.44K | -8,260 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$2.25K | -5,403 | Closed |
|
HUMAW Hedge Fund Activity: Q1 2024 in Review
6 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q1 2024, worth a combined $384K — up 15% from $333K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of HUMAW and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $116K. The largest seller was Josh Arnold Investment Consultant, exiting entirely with an estimated $108K sold.
- 6 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q1 2024, down from 9 in Q4 2023.
- Funds reported $384K of Humacyte Inc Warrant stock for Q1 2024, up 15% quarter-over-quarter.
- 2 funds opened new Humacyte Inc Warrant positions in Q1 2024 and 5 closed out, a net change of -3 holders.
- The largest Humacyte Inc Warrant buyer in Q1 2024 was Cowen and Company, an estimated $116K added.
- The largest Humacyte Inc Warrant seller in Q1 2024 was Josh Arnold Investment Consultant, an estimated $108K sold.
Based on aggregated 13F filings for Q1 2024.